Effect of Hypertrophic Cardiomyopathy Mutations in Human Cardiac Muscle α -tropomyosin (Asp175Asn and Glu180Gly) on the Regulatory Properties of Human Cardiac Troponin Determined by in vitro Motility Assay
- 31 August 2000
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 32 (8) , 1489-1498
- https://doi.org/10.1006/jmcc.2000.1182
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Altered Regulation of Cardiac Muscle Contraction by Troponin T Mutations That Cause Familial Hypertrophic CardiomyopathyJournal of Biological Chemistry, 2000
- Functional Consequences of Troponin T Mutations Found in Hypertrophic CardiomyopathyJournal of Biological Chemistry, 1999
- Properties of mutant contractile proteins that cause hypertrophic cardiomyopathyCardiovascular Research, 1999
- Altered Regulatory Function of Two Familial Hypertrophic Cardiomyopathy Troponin T MutantsBiochemistry, 1999
- Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing heartsCardiovascular Research, 1999
- Familial Hypertrophic CardiomyopathyCirculation Research, 1998
- Troponin I and troponin T interact with troponin C to produce different Ca2+-dependent effects on actin–tropomyosin filament motilityBiochemical Journal, 1997
- Effects of Two Hypertrophic Cardiomyopathy Mutations in α-Tropomyosin, Asp175Asn and Glu180Gly, on Ca2+Regulation of Thin Filament MotilityBiochemical and Biophysical Research Communications, 1997
- Calcium regulation of thin filament movement in an in vitro motility assayBiophysical Journal, 1996
- In Vitro Motility Analysis of Actin-Tropomyosin Regulation by Troponin and CalciumJournal of Biological Chemistry, 1995